Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV

Interview with Michael T. Lu, MD, MPH, author of Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial, and Matthew J. Feinstein, MD, MSc, author of Statins, Inflammation, and Tissue Context in REPRIEVE. Hosted by Robert Bonow, MD. Related Content: Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV Statins, Inflammation, and Tissue Context in REPRIEVE

You can listen to Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV online on Radio and Podcast. Open the player on this page to stream the available audio.

Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV is an episode from JAMA Cardiology Author Interviews: Covering research in cardiovascular medicine, science, & clinical practice. For physicians, researchers, & clinicians by American Medical Association.

This episode is 21:18 long.

This episode was published on Feb 21, 2024.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from JAMA Cardiology Author Interviews: Covering research in cardiovascular medicine, science, & clinical practice. For physicians, researchers, & clinicians when more episodes are available from the podcast feed.